Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.62 |
| ▸ | HPGD | P15428 | 7/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
| ▸ | NQO2 | P16083 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | NSD2 | O96028 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31267447 | 0.90 | ALDH1A1 (0.68) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL19297351 | 0.90 | ALDH1A1 (0.52) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL3861140 | 0.88 | TSHR (0.60) | HPGDSMN1; SMN2LMNAMAOBTSHR | |
| SCHEMBL8515238 | 0.88 | ALDH1A1 (0.57) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL13578052 | 0.87 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL866062 | 0.87 | ALDH1A1 (0.64) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL8515277 | 0.86 | HDAC3 (0.56) | ALDH1A1HPGDKDM4EHDAC3HDAC1 | |
| SCHEMBL31267470 | 0.85 | ALDH1A1 (0.62) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL3688021 | 0.85 | ALDH1A1 (0.62) | ALDH1A1HPGDKDM4EHSD17B10TP53 | |
| SCHEMBL1204120 | 0.85 | ALDH1A1 (0.62) | ALDH1A1HPGDKDM4EHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240369544-A1 | MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF | NOVAB, INC. | 2024-11-07 | — | — | US | claimed |
| EP-4392777-A2 | MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF | Novab, Inc. (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2023028549-A2 | MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF | NOVAB, INC. (US) | 2023-03-02 | — | — | WO | claimed |
| EP-2643340-B1 | COMPOSITIONS AND METHODS FOR FUNCTIONAL GLYCOMICS | UNIV EMORY (US) | 2019-07-31 | — | — | EP | claimed |
| US-20120083493-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2012-04-05 | — | — | US | claimed |
| EP-2268273-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2011-01-05 | — | — | EP | claimed |
| WO-2009067410-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2009-05-28 | — | — | WO | claimed |
| CN-101420942-A | Small-molecule modulators of TRP-P8 activity | DENDREON CORP (US) | 2009-04-29 | — | — | CN | claimed |
| EP-1986622-A2 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2008-11-05 | — | — | EP | claimed |
| US-20080255185-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2008-10-16 | — | — | US | claimed |
| US-20070232603-A1 | Small-molecule modulators of TRP-P8 activity | DENDREON CORPORATION (US) | 2007-10-04 | — | — | US | claimed |
| WO-2007095340-A2 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2007-08-23 | — | — | WO | claimed |
| CN-121930290-A | Efficient separation method of breast milk oligosaccharide and application of breast milk oligosaccharide in specific recognition of influenza A virus hemagglutinin protein | 西北大学 | 2026-04-28 | — | — | CN | disclosed |
| US-20240369544-A1 | MULTIVALENT GLYCAN SCAFFOLDS AND METHODS OF USE THEREOF | NOVAB, INC. | 2024-11-07 | — | — | US | disclosed |
| US-20240293553-A1 | P-SELECTIN INHIBITORS AND USES THEREOF | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2024-09-05 | — | — | US | disclosed |
| EP-4404971-A1 | P-SELECTIN INHIBITORS AND USES THEREOF | Beth Israel Deaconess Medical Center, Inc. (US) | 2024-07-31 | — | — | EP | disclosed |
| EP-1844062-A2 | INHIBITORS OF DNA METHYLTRANSFERASE | Methylgene, Inc. (CA) | 2007-10-17 | — | — | EP | disclosed |
| US-20070232603-A1 | Small-molecule modulators of TRP-P8 activity | DENDREON CORPORATION (US) | 2007-10-04 | — | — | US | disclosed |
| WO-2007095340-A2 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | DENDREON CORPORATION (US) | 2007-08-23 | — | — | WO | disclosed |
| WO-2006078752-A2 | INHIBITORS OF DNA METHYLTRANSFERASE | METHYLGENE, INC. (CA) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232603-A1 | Small-molecule modulators of TRP-P8 activity | TRPC4, TRPC3, TRPC1 | ALDH1A1 4789/4885HPGD 1644/4885KDM4E 3912/4885 |
| US-20080255185-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | TRPC4, TRPC3, TRPC1 | ALDH1A1 4789/4885HPGD 1644/4885KDM4E 3912/4885 |
| US-20120083493-A1 | SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY | TRPC4, TRPC3, TRPC1 | ALDH1A1 4789/4885HPGD 1644/4885KDM4E 3912/4885 |
| US-20240293553-A1 | P-SELECTIN INHIBITORS AND USES THEREOF | SELP, SELPLG, SELE | ALDH1A1 941/4885HPGD 659/4885KDM4E 4458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.